Investment & Partnering Strategy
What attractive acquisition opportunities are there within consumer health in Europe?
Our client, a large Private Equity firm, was looking to invest in an over-the-counter healthcare goods company in Europe to spearhead their entry into a previously unknown market.
We provided a thorough overview of the EU OTC healthcare market and its constituents to identify the top 5 investment opportunities for the client based on their strict investment criteria. The work provided a comprehensive understanding of the key competitors and market dynamics in the healthcare OTC market, as well as a prioritised selection of potential acquisitions and their particular strengths and weaknesses.
Share this post
![Testimonial about Corporate Strategy 4 Testimonial about Corporate Strategy 4](https://eradigm.com/wp-content/uploads/2022/08/Eradigm_DTx_800x500.jpg)